Article
Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with Surgery and Adjuvant Cisplatin-Based Chemoradiation.
Oncology - 1 Jan 2015
Ciaparrone Marco, Caspiani Orietta, Bicciolo Giulio, Signorelli Diego, Simonelli Ilaria, de Campora Luca, Mazzarella Giorgio, Mecozzi Antonella, Pianelli Curzio, Camaioni Angelo, Catalano Piera, Pasqualetti Patrizio, Fabiano Alfredo, Radici Marco, Marmiroli Luca, Corsi Domenico Cristiano
Abstract excerpt
OBJECTIVE: ERCC1 (excision repair cross-complementation group 1) expression predicts survival in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with chemoradiation. In order to evaluate the predictive role in the adjuvant setting, we investigated ERCC1 expression in radically resected HNSCC patients who underwent surgery and cisplatin chemoradiation. METHODS: ERCC1 expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
